Is there really good news about pandemic diabetic nephropathy?
作者信息
Friedman Eli A, Friedman Amy L
出版信息
Nephrol Dial Transplant. 2007 Mar;22(3):681-3. doi: 10.1093/ndt/gfl735. Epub 2007 Jan 5.
Abstract
摘要
相似文献
1
Is there really good news about pandemic diabetic nephropathy?关于大流行期糖尿病肾病真的有好消息吗？
Nephrol Dial Transplant. 2007 Mar;22(3):681-3. doi: 10.1093/ndt/gfl735. Epub 2007 Jan 5.
2
3
Clinical outcomes for patients with diabetic nephropathy.糖尿病肾病患者的临床结局
EDTNA ERCA J. 1999 Jan-Mar;25(1):23-7. doi: 10.1111/j.1755-6686.1999.tb00008.x.
4
Diabetic nephropathy: a global and growing threat.糖尿病肾病：一种全球性且日益严重的威胁。
Hong Kong Med J. 2010 Aug;16(4):244-5.
5
Diabetic nephropathy in hemodialysis patients in Constantine, Algeria.阿尔及利亚君士坦丁血液透析患者的糖尿病肾病
Saudi J Kidney Dis Transpl. 2015 Jan;26(1):139-40.
6
ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE.亚太肾脏病学会糖尿病肾病临床实践指南
Nephrology (Carlton). 2020 Oct;25 Suppl 2:12-45. doi: 10.1111/nep.13785.
7
[Universalistic medicine in relation to diabetes as a chronic disease at the turn of 20th and 21st centuries].[20世纪末至21世纪初普遍主义医学与作为慢性病的糖尿病的关系]
Pol Merkur Lekarski. 2002 Nov;13(77):410-2.
8
ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE - EXECUTIVE SUMMARY.亚太肾脏病学会糖尿病肾病临床实践指南——执行摘要
Nephrology (Carlton). 2020 Oct;25 Suppl 2:3-11. doi: 10.1111/nep.13763.
9
Allograft diabetic nephropathy may progress to end-stage renal disease.同种异体移植糖尿病肾病可能会进展为终末期肾病。
Pediatr Transplant. 2004 Aug;8(4):351-6. doi: 10.1111/j.1399-3046.2004.00182.x.
10
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions.2型糖尿病所致终末期肾衰竭：一场全球性的医学灾难。
Am J Kidney Dis. 1999 Nov;34(5):795-808. doi: 10.1016/S0272-6386(99)70035-1.
引用本文的文献
1
A dual COX-2/sEH inhibitor improves the metabolic profile and reduces kidney injury in Zucker diabetic fatty rat.一种双重COX-2/可溶性环氧化物水解酶抑制剂可改善Zucker糖尿病脂肪大鼠的代谢状况并减轻肾损伤。
Prostaglandins Other Lipid Mediat. 2016 Sep;125:40-7. doi: 10.1016/j.prostaglandins.2016.07.003. Epub 2016 Jul 16.
2
Effects of pyrrolidine dithiocarbamate on high-fat diet-induced metabolic and renal alterations in rats.吡咯烷二硫代氨基甲酸盐对高脂饮食诱导的大鼠代谢和肾脏改变的影响。
Life Sci. 2009 Aug 26;85(9-10):357-64. doi: 10.1016/j.lfs.2009.06.019. Epub 2009 Jul 23.
3
Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL.饮食诱导的 Zucker 大鼠的肾脏变化可以通过超氧化物歧化酶模拟物 TEMPOL 得到改善。
Obesity (Silver Spring). 2009 Nov;17(11):1994-2002. doi: 10.1038/oby.2009.137. Epub 2009 May 7.
4
Increased renal Akt/mTOR and MAPK signaling in type I diabetes in the absence of IGF type 1 receptor activation.在缺乏胰岛素样生长因子1型受体激活的情况下，I型糖尿病中肾Akt/mTOR和MAPK信号通路增强。
Endocrine. 2009 Aug;36(1):126-34. doi: 10.1007/s12020-009-9190-2. Epub 2009 Apr 23.
5
LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat.LR-90可预防Zucker糖尿病肥胖大鼠的血脂异常和糖尿病肾病。
Diabetologia. 2008 May;51(5):882-91. doi: 10.1007/s00125-008-0935-x. Epub 2008 Mar 4.
本文引用的文献
1
Influenza. New study casts doubt on plans for pandemic containment.
Science. 2006 Feb 24;311(5764):1084. doi: 10.1126/science.311.5764.1084.
2
Renoprotection of angiotensin receptor blockers: beyond blood pressure lowering.
Nephrol Dial Transplant. 2006 Apr;21(4):846-9. doi: 10.1093/ndt/gfl013. Epub 2006 Feb 13.
3
Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register.2型糖尿病中的肥胖与心血管危险因素：来自瑞典国家糖尿病登记处的结果
J Intern Med. 2006 Mar;259(3):314-22. doi: 10.1111/j.1365-2796.2006.01617.x.
4
Patient-centred and professional-directed implementation strategies for diabetes guidelines: a cluster-randomized trial-based cost-effectiveness analysis.糖尿病指南以患者为中心和专业指导的实施策略：基于整群随机试验的成本效益分析
Diabet Med. 2006 Feb;23(2):164-70. doi: 10.1111/j.1464-5491.2005.01751.x.
5
Assessment of glomerular filtration rate in addition to albuminuria is important in managing type II diabetes.除蛋白尿外，评估肾小球滤过率对于管理2型糖尿病很重要。
Kidney Int. 2006 Jan;69(2):383-7. doi: 10.1038/sj.ki.5000061.
6
Angiotensin-converting enzyme (ACE) inhibition in type 2, diabetic patients-- interaction with ACE insertion/deletion polymorphism.2型糖尿病患者中的血管紧张素转换酶（ACE）抑制作用——与ACE插入/缺失多态性的相互作用
Kidney Int. 2006 Apr;69(8):1438-43. doi: 10.1038/sj.ki.5000097.
7
Glycemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values.1型和2型糖尿病持续监测患者的血糖特征：标准值
Diabetes Care. 2005 Oct;28(10):2361-6. doi: 10.2337/diacare.28.10.2361.
8
Lifestyle modification and progressive renal failure.生活方式改变与进行性肾衰竭。
Nephrology (Carlton). 2005 Aug;10(4):387-92. doi: 10.1111/j.1440-1797.2005.00439.x.
9
Epidemic of end-stage renal disease in people with diabetes in the United States population: do we know the cause?美国糖尿病患者中终末期肾病的流行：我们知道其病因吗？
Kidney Int. 2005 May;67(5):1684-91. doi: 10.1111/j.1523-1755.2005.00265.x.
10
The evolving diabetes burden in the United States.美国不断变化的糖尿病负担。
Ann Intern Med. 2004 Jun 1;140(11):945-50. doi: 10.7326/0003-4819-140-11-200406010-00035.
Zotero 插件